MedAssets reiterates guidance for FY12 adjusted EPS $1.10 at midpoint Consensus $1.12. Reiterates view of FY12 revenue $635.0M at midpoint, consensus $636.2M. Says consolidated net revenue guidance increased by about 1.5% following its Q3 report based on nine]month 2012 performance and visibility through remainder of year. Says YTD 2012 results ahead of its expectations. Guidance and comments from presentation slides for J.P. Morgan Healthcare Conference.